Φορτώνει......
Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data
BACKGROUND: The aim of this study was to analyse registry data of seizure outcome and adverse events (AEs) for perampanel as add-on therapy in patients with focal epilepsy since its approval in 2012 for adjunctive treatment of focal epilepsy in patients ⩾12 years. METHOD: A retrospective 2-year char...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Neurol Disord |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066528/ https://ncbi.nlm.nih.gov/pubmed/27800020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616661115 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|